Rhizome AI
Agent Platform for Life Sciences
Rhizome AI is active in the b2b space based in New York City, NY, USA; Remote.
Profile
It takes 500,000 days of office work to bring a drug to market. We want to make it 5. To get there, we need agents doing most of the work.
Today, our research agent is the best way to know what the FDA thinks. Users ask a question and get an answer backed by up to 1,000 documents, where each statement has a citation.
It’s the best because we have the best retrieval engine. We’ve tuned it on our life science-specific dataset, and we find what others miss.
As more teams use Rhizome, we gain more data on what regulatory professionals actually need, which makes retrieval even better. This flywheel is how we become the retrieval engine that powers all human and agent work in life sciences.
Chetan started his career as a research engineer, but quickly realized he enjoyed building more than research. He joined EvolutionaryScale as their sole founding product engineer, launching their developer-scientist platform and scaling to tens of thousands of users and billions of API calls. He was also #16 at Instabase helping banks with document processing, closing $7m as the technical closer.
Agents can do magical things today, but most in life sciences only use them to edit emails. Agents are missing the context they need to 100x the number of drugs we can bring to market. Rhizome AI is focused on that critical problem.
Within the b2b space, the company focuses on its core offering rather than a broad product line.
New York City, NY, USA; Remote is where the company is located.
The company is listed at the Winter 2026 stage of development.
The company reports a headcount in the 1 range.
Directory analysis
Rhizome AI is a B2B agent platform that automates regulatory research for life‑science companies, aiming to cut the time required to bring a drug to market from 500,000 days to five. Its research agent answers FDA‑related questions using a specialized retrieval engine that pulls up to 1,000 documents, each with citations, and improves over time through user interactions. The platform positions itself as a tool that learns from real regulatory workflows to provide increasingly accurate information.
Positioning: Rhizome AI targets regulatory professionals in the pharmaceutical and biotech sectors, offering a niche AI solution that could reduce manual research effort. Its market positioning hinges on the quality of its life‑science‑specific knowledge base and the willingness of teams to adopt an agent‑driven workflow.
Note: Rhizome AI provides AI‑driven regulatory research for life science companies.
Auto-generated directory analysis from public data · updated 8 Oct 2026. Informational only, not investment advice.
| Sector | B2B |
|---|---|
| Headquarters | New York City, NY, USA; Remote |
| Country | USA; Remote |
| Employees | 1 |
| Stage | Winter 2026 |
Website: rhizomeai.com
Browse related
Create a free account